Asthma Clinical Trial
Official title:
Dietary and Genetic Factors in Asthma & Chronic Bronchitis in a Cohort of Chinese Singaporeans
There is suggestive evidence for a role of dietary in the etiology of asthma and chronic
bronchitis. However, there are few prospective data. We propose to expand our collaboration
with the Singapore Chinese Health Study to examine dietary, environmental, and genetic
factors, along with their interactions, in relation to the risk of developing asthma and
chronic bronchitis. The Singapore Chinese Health Study is a cohort of 63,257 men and women of
Chinese ethnicity in Singapore who were aged 45-74 years at enrollment from 1993 to 1998.
Telephone follow-up of the cohort to update and outcome information began in 1999 and is
ongoing. We expect to identify 538 cases of incident asthma and 672 cases of incident chronic
bronchitis when the current follow-up questionnaire cycle is complete in 2004. In this
proposal, we would validate self-reports of incident asthma, obtain follow-up data from the
entire cohort to perform analyses of dietary and smoking in relation to these outcomes, and
analyze genetic material on cases of incident asthma and chronic bronchitis and controls from
the cohort. In this proposal we will examine the following hypotheses:
1. Higher intake of fruits and/or antioxidant micronutrients decreases the risk of
developing asthma and chronic bronchitis.
a. Effects if fruit and/or antioxidant micronutrients may differ by smoking history.
2. Common polymorphisms in genes involved in the response to oxidative stress influence the
risk of asthma and chronic Bronchitis. We initially propose to examine polymorphisms in
three genes--glutathione S-tranferase M1, glutahione S-transferase P1, and matrix
metalloproteinase-1. However, we plan to examine additional relevant polymorphisms in
the future, especially taking advantage of high throughput screens of candidate genes
for asthma and chronic bronchitis. It is possible that by 2004 when the sample set will
be available that more compelling candidates and high throughput screens may be
available to us at a low cost. Thus we will re-evaluate our choice when the samples are
available.
3. Polymorphisms in these and other genes interact with fruit/antioxidant intake and/or
smoking to influence the risk of asthma and chronic bronchitis.
There is suggestive evidence for a role of diet in the etiology of asthma and chronic
bronchitis. However, there are few prospective data. We propose to expand our collaboration
with the Singapore Chinese Health Study to examine dietary, environmental, and genetic
factors, along with their interactions, in relation to the risk of developing asthma and
chronic bronchitis. The Singapore Chinese Health Study (NIH grant CA080205) is a cohort of
63,257 men and women of Chinese ethnicity in Singapore who were aged 45-74 years at
enrollment from 1993 to 1998. Telephone follow-up of the cohort to update and outcome
information began in 1999 and is ongoing. We expect to identify 538 cases of incident asthma
and 672 cases of incident chronic bronchitis when the current follow-up questionnaire cycle
is complete in 2004. In this proposal, we would validate self-reports of incident asthma,
obtain follow-up data from the entire cohort to perform analyses of diet and smoking in
relation to these outcomes, and analyze genetic material on cases of incident asthma and
chronic bronchitis and controls from the cohort. In this proposal we will examine the
following hypotheses:
1. Higher intake of fruits and/or antioxidant micronutrients decreases the risk of
developing asthma and chronic bronchitis.
a. Effects of fruit and/or antioxidant micronutrients may differ by smoking history
2. Common polymorphisms in genes involved in the response to oxidative stress influence the
risk of asthma and chronic bronchitis. We initially propose to examine polymorphisms in
three genes -- glutathione S-tranferase M1, glutathione S-transferase P1, and matrix
metalloproteinase-1. However, we plan to examine additional relevant polymorphisms in
the future, especially taking advantage of high throughput screens of candidate genes
for asthma and chronic bronchitis. It is possible that by 2004 when the sample set will
be available that more compelling candidates and high throughput screens may be
available to us at a low cost. Thus we will re-evaluate our choice when the samples are
available.
3. Polymorphisms in these and other genes interact with fruit/antioxidant intake and/or
smoking to influence the risk of asthma and chronic bronchitis.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04624425 -
Additional Effects of Segmental Breathing In Asthma
|
N/A | |
Terminated |
NCT04410523 -
Study of Efficacy and Safety of CSJ117 in Patients With Severe Uncontrolled Asthma
|
Phase 2 | |
Active, not recruiting |
NCT03927820 -
A Pharmacist-Led Intervention to Increase Inhaler Access and Reduce Hospital Readmissions (PILLAR)
|
N/A | |
Completed |
NCT04617015 -
Defining and Treating Depression-related Asthma
|
Early Phase 1 | |
Recruiting |
NCT03694158 -
Investigating Dupilumab's Effect in Asthma by Genotype
|
Phase 4 | |
Terminated |
NCT04946318 -
Study of Safety of CSJ117 in Participants With Moderate to Severe Uncontrolled Asthma
|
Phase 2 | |
Completed |
NCT04450108 -
Vivatmo Pro™ for Fractional Exhaled Nitric Oxide (FeNO) Monitoring in U.S. Asthmatic Patients
|
N/A | |
Completed |
NCT03086460 -
A Dose Ranging Study With CHF 1531 in Subjects With Asthma (FLASH)
|
Phase 2 | |
Completed |
NCT01160224 -
Oral GW766944 (Oral CCR3 Antagonist)
|
Phase 2 | |
Completed |
NCT03186209 -
Efficacy and Safety Study of Benralizumab in Patients With Uncontrolled Asthma on Medium to High Dose Inhaled Corticosteroid Plus LABA (MIRACLE)
|
Phase 3 | |
Completed |
NCT02502734 -
Effect of Inhaled Fluticasone Furoate on Short-term Growth in Paediatric Subjects With Asthma
|
Phase 3 | |
Completed |
NCT01715844 -
L-Citrulline Supplementation Pilot Study for Overweight Late Onset Asthmatics
|
Phase 1 | |
Terminated |
NCT04993443 -
First-In-Human Study to Evaluate the Safety, Tolerability, Immunogenicity, and Pharmacokinetics of LQ036
|
Phase 1 | |
Completed |
NCT02787863 -
Clinical and Immunological Efficiency of Bacterial Vaccines at Adult Patients With Bronchopulmonary Pathology
|
Phase 4 | |
Recruiting |
NCT06033833 -
Long-term Safety and Efficacy Evaluation of Subcutaneous Amlitelimab in Adult Participants With Moderate-to-severe Asthma Who Completed Treatment Period of Previous Amlitelimab Asthma Clinical Study
|
Phase 2 | |
Completed |
NCT03257995 -
Pharmacodynamics, Safety, Tolerability, and Pharmacokinetics of Two Orally Inhaled Indacaterol Salts in Adult Subjects With Asthma.
|
Phase 2 | |
Completed |
NCT02212483 -
Clinical Effectiveness and Economical Impact of Medical Indoor Environment Counselors Visiting Homes of Asthma Patients
|
N/A | |
Recruiting |
NCT04872309 -
MUlti-nuclear MR Imaging Investigation of Respiratory Disease-associated CHanges in Lung Physiology
|
||
Withdrawn |
NCT01468805 -
Childhood Asthma Reduction Study
|
N/A | |
Recruiting |
NCT05145894 -
Differentiation of Asthma/COPD Exacerbation and Stable State Using Automated Lung Sound Analysis With LungPass Device
|